Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors, Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03265080
What this trial is testing

ADXS-NEO Expressing Personalized Tumor Antigens

Who this might be right for
Colon Cancer MetastaticHead and Neck Cancer MetastaticMetastatic Non-Small Cell Lung Cancer+2 more
Advaxis, Inc. 13
Testing effectiveness (Phase 2)UnknownNCT03797391
What this trial is testing

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisNon-Small-Cell Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd. 186
Early research (Phase 1)Study completedNCT03307785
What this trial is testing

Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

Who this might be right for
NeoplasmsMetastatic CancerAdvanced Cancer+4 more
Tesaro, Inc. 60
Early research (Phase 1)Study completedNCT04544748
What this trial is testing

GNR-051 in Subjects With Advanced Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma
AO GENERIUM 48
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Early research (Phase 1)Study completedNCT01602289
What this trial is testing

LY2875358 in Japanese Participants With Advanced Cancer

Who this might be right for
Solid TumorsLymphomaCarcinoma, Non-Small-Cell Lung
Eli Lilly and Company 17
Early research (Phase 1)Ended earlyNCT01219543
What this trial is testing

A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.

Who this might be right for
Solid TumourAdvanced Solid MalignanciesChild-Pugh A to B7 Advanced Hepatocellular Carcinoma+3 more
AstraZeneca 47
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT03565003
What this trial is testing

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 126
Early research (Phase 1)Study completedNCT03096054
What this trial is testing

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

Who this might be right for
Colorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more
Cancer Research UK 69
Testing effectiveness (Phase 2)Ended earlyNCT05543629
What this trial is testing

BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

Who this might be right for
Advanced Solid TumorsNon-small Cell Lung Cancer
Bristol-Myers Squibb 36
Early research (Phase 1)Not Yet RecruitingNCT07624214
What this trial is testing

Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. 198
Not applicableLooking for participantsNCT06431100
What this trial is testing

A Single-arm, Single-center, Open Clinical Study

Who this might be right for
Gastric CancerEsophageal CancerCervical Cancer+2 more
Beijing Geekgene Technology Co., LTD 10
Early research (Phase 1)Active Not RecruitingNCT04794699
What this trial is testing

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Who this might be right for
Solid Tumor
IDEAYA Biosciences 169
Early research (Phase 1)Active Not RecruitingNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 148
Early research (Phase 1)Ended earlyNCT04190628
What this trial is testing

Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorBRAF V600 Mutation
ABM Therapeutics Corporation 53
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Early research (Phase 1)Temporarily pausedNCT04418167
What this trial is testing

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

Who this might be right for
Solid Tumors
JS InnoPharm, LLC 71
Testing effectiveness (Phase 2)Study completedNCT02108964
What this trial is testing

A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies

Who this might be right for
Advanced Non-small Cell Lung Cancer
Novartis Pharmaceuticals 225
Next Page